The forecast for nervous system medicine sales in Japan from 2024 to 2028 shows a steady growth. The values are projected to increase each year, with a consistent year-on-year growth of approximately 1.4-1.5%. For instance, sales are expected to rise from 73.7 USD per capita in 2024 to 77.8 USD per capita in 2028. The compound annual growth rate (CAGR) over this five-year period is approximately 1.4% per year.
This trend illustrates a consistent and modest increase in demand for nervous system medicines. This increase could be due to a growing aging population, advancements in medical technology, and an increase in the prevalence of neurological conditions.
Future trends to watch for include potential market disruptions from new medical treatments, the impact of healthcare policy changes, and advancements in biotechnology. Monitoring these trends will be crucial for stakeholders in the nervous system medicine market in Japan.
